Clinical trials

174

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Follow-up After Oncological Resection by Endoscopic Colorectal ESD

Colorectal cancer is a common and leading cause of death. Pre-cancerous lesions, as well as some so-called superficial cancers, can be resected via endoscopy. The technique chosen in the case of extensive lesions or superficial cancer is submucosal dissection. This technique helps avoid surgery, which has a higher morbidity and mortality (especially due to the non-preservation of the organ).

Participants needed: 1,200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Oct 13, 2026Locations: 14
Eligibility criteria

Adult patient (18 years or older). [+3]

History of Crohn's disease (ICD-10: K50) or ulcerative colitis (ICD-10: K51). [+4]

Status: Not yet recruiting

Brain Iron in Beta-Propeller Protein Associated Neurodegeneration (BPAN)

This study aims to quantify intracerebral iron load in patients with Beta-Propeller Protein-Associated Neurodegeneration (BPAN) using Quantitative Susceptibility Mapping (QSM) technique. The primary objective is to assess the longitudinal robustness of QSM measurements over an 18-month follow-up. This pilot study also explores the relationship between iron accumulation and clinical severity. Ultimately, it seeks to validate QSM as a non-invasive biomarker for disease monitoring and future therapeutic trials

Participants needed: 3
Trial details
Age: 5-18Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Oct 9, 2026Locations: 1
Eligibility criteria

Affiliation to a social security system [+4]

Presence of a pacemaker, neurostimulator, or implantable defibrillator (risk of... [+5]

Status: Recruiting

Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.

Participants needed: 592
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Sep 24, 2026Locations: 15
Eligibility criteria

Patients over 18 years of age with indication for colonoscopy as part of a scree... [+2]

Failed complete colonoscopy, defined by the absence of cecal intubation or ident... [+8]

Status: Recruiting

Functional Connectivity of the Interoceptive Network in RLS

Restless Legs Syndrome (RLS) is a sensorimotor disorder primarily characterized by an irresistible urge to move the legs while at rest. A key hypothesis suggests that RLS symptoms are linked to abnormal brain function in processing internally generated stimuli, particularly interoception. This distorted perception of the internal bodily state leads to maladaptive behaviors, which may manifest across a wide range of medical and psychiatric disorders. Here, the investigators hypothesize that dysfunction in the insular cortex (IC) may result in a failure of behavioral adaptation, primarily expressed as an urge to move the legs and hyperarousal, even when the body and mind need rest. This project aims to assess the relationship between interoceptive abilities and diurnal fluctuations in IC functional connectivity (FC) in patients with RLS compared to healthy controls. The investigators will also examine correlations between the FC of the interoceptive network, measured in the morning and evening on the same day, using multilayer network analysis, daily fluctuations in RLS symptom severity, and objective measurements of the sleep/wake cycle, gathered through a two-week ambulatory assessment using mobile technologies such as Ecological Momentary Assessment (EMA) and actigraphy, along with scores from self-reported questionnaires. The findings may provide strong evidence to support or refute the hypothesis of interoceptive dysfunction in RLS patients.

Participants needed: 30
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Sep 25, 2026Locations: 1
Eligibility criteria

Person aged from 18 to 70 years [+4]

Any significant psychiatric illness or mood disorder [+6]

Status: Not yet recruiting

Patient-Perceived Symptoms at the Center of Obstructive Sleep Apnea (OSA) Management: Validation of the French Version of the Patient-Reported Apnea Questionnaire (PRAQ)

Obstructive sleep apnea (OSA) is a common and disabling sleep disorder in which the assessment and monitoring of symptoms are central to patient management. However, these steps require a shared understanding of the disease's clinical manifestations among patients, caregivers, and healthcare professionals in order to establish common therapeutic goals and meaningful clinical outcomes. Improving symptoms as experienced and reported by patients has become a major public health priority at both the national and international levels. In France, this patient-centered approach has been identified as a strategic priority by the French National Authority for Health (Haute Autorité de Santé, HAS) in its 2019-2024 strategic plan. Its implementation has been supported through the development and use of Patient-Reported Outcome Measures (PROMs). A disease-specific PROM for OSA, the Patient-Reported Apnea Questionnaire (PRAQ), has recently been developed and validated. The primary objective of this study is to validate a French version of the PRAQ. Secondary objectives are to evaluate the relationship between PRAQ scores and subjective sleep parameters, and to develop a shortened version of the questionnaire to facilitate its use in both clinical practice and research.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Sep 23, 2026Locations: 1
Eligibility criteria

Age > 18 years [+6]

Current psychiatric disorder (mood disorders, anxiety, psychosis, substance use... [+5]

Status: Not yet recruiting

Simplified Acute Physiology Score 2 and Pressure Ulcer Prediction in ICU.

Critically ill patients admitted in intensive care units are at high risk of developing pressure ulcer (also known as pressure injury). In Bordeaux teaching hospital, a prevalence survey identified the department of anaesthesia and Intensive Care Unit with the highest rate for pressure ulcer (up to 29% of patients). Yet, developing a PU will increase patient's pain, health expenses, and the risks for further complications such as infection, prolonged hospitalization and a higher mortality rate. Therefore, this study aims at improving pressure ulcer prediction by using the Simplified Acute Physiology Score 2 (SAPS 2) as the latter estimates the severity of a patient condition while factoring in several causative factors for pressure ulcer among ICU patients. This could then lead to a better use and allocation of human and material resources and improve patients' care.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Sep 9, 2026Locations: 1
Eligibility criteria

Adults ≥ 18 years of age; [+3]

Length of stay less than 24 hours; [+3]

Status: Recruiting

Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma

The EVOLUTION is a 10-year extension of the ENVOL study. It seeks to compare the evolution of structural and functional connectivity (Hub Disruption Index) and cerebral volume on 3T MRI of the brain in glaucoma patients and matched controls. The study aims to examine the hypothesis that glaucomatous optic neuropathy is not limited solely to the visual pathway, but rather is associated with a broader degeneration of the central nervous system.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Sep 3, 2026Locations: 1
Eligibility criteria

having been previously included and completed the ENVOL study [+13]

Inability/unwillingness to provide informed consent [+6]

Status: Not yet recruiting

Characterisation of MNEsic Involvement in Patients With Obesity.

The aim of the study is therefore to characterise memory impairment in a middle-aged population with obesity and to clarify the role of inflammation in obesity-related memory impairment. The hypothesise that, as in an elderly population, neurological and memory impairment in a population of middle-aged obese individuals is heterogeneous, with varying levels of memory impairment characterised by neuropsychological test results. This heterogeneity in neuropsychological tests may be linked to markers of inflammation and brain imaging biomarkers identified previously in the litterature.

Participants needed: 150
Trial details
Age: 30-50Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Sep 1, 2026
Eligibility criteria

Patients suffering from obesity with a BMI between 30 and 45 kg/m² [+4]

Patients currently undergoing treatment with neuroleptics or who have stopped tr... [+13]

Status: Recruiting

Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections

The purpose of this trial is to demonstrate that when treating acute cystitis without risk of complication, pharmacists may use share Decision Making tool to help patients to better understand the stakes of taking antibiotics and adapt the management of the delegation protocol. This will select patients in need of antibiotics and preserve the full-capacities of non-treated one.

Participants needed: 506
Trial details
Age: 18-65Biological sex: FemaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Sep 1, 2026Locations: 26
Eligibility criteria

woman, [+3]

anomaly of the urinary canal, [+9]

Status: Not yet recruiting

Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE

The biological samples and associated data will facilitate the successful implementation of the research collaboration between Bordeaux University Hospital and the University of Bordeaux on the pathophysiology of bronchopulmonary diseases. In the longer term, this research could lead to the discovery of new therapeutic targets for asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and acute respiratory distress syndrome.

Participants needed: 650
Trial details
Age: 1-80Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Aug 21, 2026Locations: 1Duration: 1 Day
Eligibility criteria

Male or female [+3]

Patient or holder of parental authority for children who have expressed their op...

Status: Recruiting

Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.

This prospective, single-center, randomized study will evaluate the impact of implementing an educational nursing consultation at the end of hospitalisation for stroke patients returning home on overall adherence to stroke-related medication during the 4-month follow-up visit.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Aug 18, 2026Locations: 1
Eligibility criteria

Patients admitted to the Neurovascular Unit (UNV) of CHCB for ischemic stroke an... [+6]

Patients admitted for mechanical thrombectomy, outside the Basque Coast Hospital... [+3]

Status: Not yet recruiting

Multicentre Study Evaluating the Efficacy of a 7-day Course of Doxycycline for the Treatment of Asymptomatic Anal Lymphogranuloma Venereum.

Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by the L genotypes of C. trachomatis. Proctitis is the main clinical manifestation of infection in the current LGV epidemic. However, recent European studies reported that about 25% of the anal LGV infections are asymptomatic. In France, asymptomatic anal LGV increased from 36.1% (44/124) in 2020 to 52.4% (66/126) in 2022. LGV testing is recommended on all C. trachomatis-positive anorectal specimens because therapy of extended duration is required. Patients with anal C. trachomatis infection should be treated initially with 7-day course of doxycycline (200 mg per day orally) while awaiting the results of LGV testing. Treatment should be extended to 21 days in cases of LGV according to current European and USA guidelines for LGV treatment. This regimen is indicated for symptomatic and asymptomatic anorectal LGV, with a 98.5% treatment efficacy. However, there is no obvious biological basis for prolonged treatment of asymptomatic LGV. Three recent retrospective studies showed that a 7-day course of doxycycline was effective for the treatment of asymptomatic LGV, with microbial cure ranging from 97% (38/39) to 100% (54/54). The objective of this study is to evaluate the efficacy (microbiological cure rate) of a 7-day course of doxycycline 200 mg daily orally for the treatment of asymptomatic anal LGV infection, four weeks after treatment initiation.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Aug 17, 2026Locations: 14
Eligibility criteria

Age ≥ 18 years [+9]

Individual with anorectal symptoms [+12]

Status: Recruiting

Identification and Description of Patients With High-risk Non Metastatic RCC

Renal cell carcinoma (RCC) is the 14th most common cancer worldwide. Surgery is the standard of care for localized RCC, however, the risk of recurrence varies widely among patients. Adjuvant pembrolizumab has been shown to improve outcomes after nephrectomy but is associated with substantial toxicity and high costs. This study uses real-world data from the French UroCCR-Chain registry to characterize the natural history, management, and outcomes of non-metastatic RCC in France, with the aim of informing adjuvant treatment decisions

Participants needed: 6,109
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Aug 7, 2026Locations: 1
Eligibility criteria

Adult patients diagnosed with local RCC or high-risk locally advanced RCC, [+2]

Patients with metastatic disease at inclusion, [+2]

Status: Recruiting

A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Aug 7, 2026Locations: 1
Eligibility criteria

Patients of 18 years or older, with highly suspected glioblastoma on neuro-image... [+3]

Patients under guardianship, curatorship or protective supervision [+3]

Status: Not yet recruiting

Echo-guided Scalp Blocks and Incidence of Postoperative Pain in Scheduled Supratentorial Intracranial Surgery.

Up to 30% of patients undergoing intracranial surgery present moderate to severe pain. In this type of surgery, the restriction of the pharmacopoeia, which goes against the concept of multimodal analgesia, results in the important use of opioids not without consequences in terms of complications. Numerous studies have highlighted the benefits of scalp blocks in postoperative pain. The originality of this study lies firstly in the fact that the scalp blocks will be guided by ultrasound and secondly, the incidence of severe pain after scalp blocks will be evaluated

Participants needed: 230
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Aug 7, 2026Locations: 1
Eligibility criteria

Patient managed in the neurosurgical unit for supratentorial intracranial surger... [+2]

Surgical procedure under awake surgery (systematic realization of scalp blocks n... [+6]

Status: Not yet recruiting

Evaluation of the Effectiveness of Extending the "Passerelle" System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)

Type 2 diabetes is on the increase worldwide. Two major risk factors have been identified: overweight and physical inactivity. National and international recommendations encourage general practitioner to guide patients in changing their lifestyle. As regards physical activity in France, general practitioner have been able to prescribe adapted physical activity (APA) for their patients since 2016. In type 2 diabetes, it is known that physical activity interventions are cost-effective. However, these interventions are often too expensive and far removed from real life. It is also known that the benefits of intervention increase up to 18 months, then diminish to zero at 36 months. In Nouvelle-Aquitaine, France, the "PEPS Sport-santé network", offers physical activity coaching for patients who are not sufficiently active: the "Passerelle" program. Patients can benefit from a weekly physical activity session for 6 months. The investigators would therefore like to assess whether extending the existing "Passerelle program" by 6 months, with one session every 15 days, is effective in maintaining the volume of physical activity 12 months after the end of the intervention.

Participants needed: 308
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Aug 7, 2026Locations: 1
Eligibility criteria

Patients with type 2 diabetes with initial diagnosis of fasting blood glucose >... [+7]

Cardiovascular: unstable angina, stress angina, malignant hypertension, recent m... [+5]

Status: Recruiting

Peripheral Helper T-cells in Common Variable ImmunoDeficiency

The aim is to determine whether whether Tph could support non-infectious complications through providing help to pathological B-cells.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Aug 5, 2026Locations: 1
Eligibility criteria

Male or female; [+4]

Patients on corticosteroids and/or immunosuppressants; [+4]

Status: Recruiting

AGE Accumulation in Patients on Long-term Parenteral Nutrition

This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting long-term parenteral nutrition, by non-invasive skin AGE measurements over a 12-month follow-up.

Participants needed: 50
Trial details
Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 24, 2026Locations: 3
Eligibility criteria

Patients (adults and children, all ages) initiating long-term parenteral nutriti... [+3]

Fitzpatrick skin type ≥ V (darker skin tones) [+3]

Status: Not yet recruiting

Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia

Acute myeloid leukemia (AML) with FLT3 mutation accounts for 30% of patients and is associated with a poor prognosis. Because of the FLT3 mutation, a tyrosine kinase inhibitor, midostaurin (MIDO), is added to the standard treatment with daunorubicin and cytarabine, from D8 to D21 of induction and of each consolidation cycle, followed by one year of maintenance. Venetoclax (VEN), a BCL2 inhibitor, has revolutionized the management of AML patients ineligible for intensive chemotherapy, in combination with azacitidine or cytarabine. The investigators hypothesize that a four-drug induction regimen (daunorubicin+cytarabine+MIDO+VEN) will increase complete remission (CR) rate without measurable residual disease (MRD) and improve event free survival (EFS), relapse free survival (RFS) and overall survival (OS) of this subgroup of patients with unmet medical need.

Participants needed: 41
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 24, 2026Locations: 3
Eligibility criteria

Age ≥18 years and ≤70 years [+3]

Prior treatment for AML or myelodysplastic (MDS) phase. [+5]

Status: Not yet recruiting

Abnormality of the Central Canal of the Spinal Cord in Syringomyelia in a Patient With a Basal Skull Malformation

The aim of this study is to analyze the association between a deformity of the cranial portion of the central spinal canal and syringomyelia in patients with a Chiari-type malformation of the craniocervical junction. The investigators hypothesize that Chiari malformation, defined by the herniation of the cerebellar tonsils through the foramen magnum, may be responsible for a deformation of the cranial portion of the central spinal canal, and that this deformation is associated with the presence of syringomyelia in patients with this malformation.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 22, 2026Locations: 1
Eligibility criteria

Adult patients being treated for Chiari malformation or syringomyelia at Bordeau... [+3]

Pregnant or breastfeeding patients [+4]

Status: Recruiting

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

Emphysema linked to alpha-1-antitrypsin deficiency (DAAT): towards a better prediction of risks Emphysema caused by alpha-1-antitrypsin deficiency (DAAT) is a rare genetic disorder that can lead to serious complications, such as the need for a lung transplant or death, affecting up to 15% of patients. The only specific treatment available is a weekly infusion of alpha-1-antitrypsin (IV-AAT), an expensive and burdensome therapy. Currently, there is no reliable model to predict the course of the disease in these patients. Our study, conducted in several French hospitals, aims to develop a prediction tool combining clinical, biological, functional data and advanced medical image analysis (lung CT). This model will make it possible to identify the most at-risk patients, in order to better adapt their care, anticipate transplant needs and avoid unnecessary treatments for low-risk patients. Ultimately, this approach could also improve access to care for patients who need it most, while optimizing health system resources.

Participants needed: 230
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Jul 20, 2026Locations: 4
Eligibility criteria

diagnosed between 2010 and 2025 [+3]

Age <18 years [+5]

Status: Not yet recruiting

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

Immunologic thrombocytopenic purpura (ITP) in children is a pre-lupus condition if associated with the presence of anti-nuclear antibodies (ANA), providing a unique model for understanding the natural history of autoimmunity, particularly that of systemic lupus erythematosus (SLE). The investigators will describe the shared and/or unique immunological pathways involved at diagnosis in 70 children with ITP and in 20 children with SLE, and compare them between ITP-ANA- (more often transient), ITP-ANA+ (pre-lupus condition, more often persistent) and SLE

Participants needed: 105
Trial details
Age: 1-18Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 17, 2026Locations: 2
Eligibility criteria

Child or adolescent with newly diagnosed ITP or SLE according to the specific de... [+8]

ITP secondary to a known cause: previous or concomitant immune deficiency, bone... [+6]

Status: Recruiting

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)

Graft versus Host Disease (GVHD) is frequent after allogeneic stem cell transplantation (alloSCT). GVHD occurs following 2 patterns : acute GVHD (aGVHD) or chronic GVHD (cGVHD). The latter occurs in nearly 50% of patients and its pathogenesis remains poorly understood. Previous translational studies have delineated biological immune dysregulation involved in cGVHD and facilitated the development of new drug and therapeutic strategies. New aspects of T and B cells collaboration in the context of cGVHD using blood description of a key player called TFH, classicaly involved in germinal center reaction, were previously uncovered (Forcade et al, Blood 2016). Previous studies in the context of auto-immune inflammation (lupus nephritis) or organ transplant rejection, suggested that target tissue could contain accessory lymphoid structures (TLS). The description of such structures in cGVHD target tissue would give the opportunity to directly analyze immune key player involved the pathogenesis of cGVHD.

Participants needed: 70
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 16, 2026Locations: 1
Eligibility criteria

Patient > 18 yo ; [+7]

Patient below 18 yo or unable to give consent ; [+3]

Status: Recruiting

Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules

Lung cancer screening trials using low-dose chest CT scans have shown a significant reduction of cancer related mortality in subjects at high risk of lung cancer. However, high rate of false positives and overdiagnosis have led to invasive methods, which are not without risks. Evaluation of lung nodules using lung MRI with ultra short echo time sequences (UTE) has been found comparable to chest CT scans. Moreover, MRI has the advantage of multiparametric characterization of lesions using different tissue contrasts. Following the recommendation of the French National Authority for Health (HAS) to evaluate new methods of lung cancer screening, this prospective single center pilot study is designed to evaluate the performance of multiparametric lung MRI combined to synthetic CT in the diagnosis of lung cancer in heavily smokers or ex-smokers professionally exposed to carcinogens

Participants needed: 50
Trial details
Age: 55-74Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 9, 2026Locations: 1
Eligibility criteria

Subject aged between 55 and 74 years [+5]

Subject with signs of lung cancer [+9]

Status: Recruiting

Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)

Remarkable progress in paediatric cardiology and surgery have led to the substantial increase of congenital heart disease (CHD) survivors. Long-term outcomes in rare and complex CHD have become a critical priority as three major sources of morbidity have been identified in this population: neurodevelopmental sequelae, mental health issues and reduced exercise capacity. These challenges adversely affect their quality of life and constitute a major public health issue. We seek to evaluate the efficacy of the first integrative and holistic program in Neuro-Cardiac Health associating physical and psychological rehabilitation for children with rare CHD compared to the standard of care. Children randomly assigned to the intervention will undergo a 12-week neuro-cardiac intervention including home-based adaptive physical exercise, telehealth parent and child psycho-education and child computerized cognitive training, as well in-person individual sessions of intervention reinforcement. Parents will be actively involved and will receive personalized feedback and educational resources. Children assigned to the control group will receive the standard of care in congenital cardiology. Post-intervention effects will be measured after 12-months on several outcomes including health-related quality of life (HRQoL), trained and untrained cognitive skills, mental health outcomes and cardiovascular/physical variables.

Participants needed: 192
Trial details
Age: 8-25Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 8, 2026Locations: 6
Eligibility criteria

Patient with a CHD of moderate to great complexity as defined in the 2019 AHA/AC... [+4]

Unstable and/or severe heart failure: severe heart failure (class IV NYHA functi... [+24]